Category: 2022
2 min read
Investment raises hopes of new dementia treatments University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia. The Dementia Discovery Fund (DDF) has…
3 min read
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.A successful collaboration between the University of Dundee…
1 min read
On 24th November the University of Dundee hosted a highly productive visit by a delegation from UKRI, including their Chief Executive, Professor Dame Ottoline Leyser and the Executive Chair of MRC Professor John Iredale, see UKRI news for more…
1 min read
Watch the video of the online seminar for Illuminating the role of SMARCA2/4 in childhood alveolar rhabdomyosarcoma by targeted protein degradation with ACB1.
3 min read
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy. An international collaboration, featuring…
2 min read
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge. *A molecule…
2 min read
A research publication by Tasuku Ishida and Alessio Ciulli has been named one of the 2021 SLAS Readers Choice Award winners. The annual awards from the Society for Laboratory Automation and Screening (SLAS) honour articles and…
3 min read
Spinout named a ‘Fierce 15’ Biotech Companies of 2022 University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies. University of Dundee spinout Amphista Therapeutics has been designated…
3 min read
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein. Parkinson’s disease is a progressive neurodegenerative disorder affecting more than 10 million people worldwide. No cure is available…
1 min read
Now published in Chemical Society Reviews: Claudia & Alessio’s review on VHL ligands and their use as VHL inhibitors and in PROTAC degraders. Read the full article open access. Authors: Claudia J. Diehl, Alessio Ciulli* Title:…